Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2022 Dec 17;21(3):604–616. doi: 10.1016/j.cgh.2022.12.008

Figure 3.

Figure 3.

Microbiome-based assays for CRC detection take advantage of the differences in bacterial species, viruses, fungi, and microbiome-generated metabolites between stool from CRC/AA-associated and health-associated microbiomes to develop biomarkers that can be used for CRC or AA detection, either independently or along with established tests such as FOBT, FIT, or MT-sDNA.